Hematopoietic stem cell transplantation for children with acute myeloid leukemia in second remission: A report from the Australasian Bone Marrow Transplant Recipient Registry and the Australian and New Zealand Children's Haematology Oncology Group.
Adrian SelimFrank AlvaroCatherine H ColeChris J FraserFrancoise MechinaudTracey A O'BrienPeter J ShawHeather TappLochie TeagueIan Nivison-SmithAndrew S MoorePublished in: Pediatric blood & cancer (2019)
These data suggest that a second chemotherapy cycle pre-HSCT may improve survival by lowering disease burden. Prospective trials assessing strategies to reduce pre-HSCT MRD in relapsed childhood AML are warranted.
Keyphrases
- acute myeloid leukemia
- bone marrow
- allogeneic hematopoietic stem cell transplantation
- young adults
- mesenchymal stem cells
- palliative care
- acute lymphoblastic leukemia
- hematopoietic stem cell
- electronic health record
- squamous cell carcinoma
- big data
- diffuse large b cell lymphoma
- rheumatoid arthritis
- locally advanced
- rectal cancer
- childhood cancer